Improved detection of tryptic immunoglobulin variable region peptides by chromatographic and gas-phase fractionation techniques

peer-reviewed · Cell Reports Methods · 2024

peer-reviewed · Cell Reports Methods · 2024. Christoph Stingl et al. The polyclonal repertoire of circulating antibodies potentially holds valuable information about an…
Date 2024-06-01
Type peer-reviewed
Venue Cell Reports Methods
Publisher Elsevier BV
Contribution downstream-application
DOI 10.1016/j.crmeth.2024.100795
Citations (OpenAlex) 0

Abstract

The polyclonal repertoire of circulating antibodies potentially holds valuable information about an individual’s humoral immune state. While bottom-up proteomics is well suited for serum proteomics, the vast number of antibodies and dynamic range of serum challenge this analysis. To acquire the serum proteome more comprehensively, we incorporated high-field asymmetric waveform ion-mobility spectrometry (FAIMS) or two-dimensional chromatography into standard trypsin-based bottom-up proteomics. Thereby, the number of variable region (VR)-related spectra increased 1.7-fold with FAIMS and 10-fold with chromatography fractionation. To match antibody VRs to spectra, we combined de novo searching and BLAST alignment. Validation of this approach showed that, as peptide length increased, the de novo accuracy decreased and BLAST performance increased. Through in silico calculations on antibody repository sequences, we determined the uniqueness of tryptic VR peptides and their suitability as antibody surrogate. Approximately one-third of these peptides were unique, and about one-third of all antibodies contained at least one unique peptide.

Authors

  1. Christoph Stingl · Erasmus MC
  2. Martijn M. VanDuijn · Erasmus MC, Erasmus University Rotterdam
  3. Thomas Dejoie · Centre Hospitalier Universitaire de Nantes
  4. Peter A. E. Sillevis Smitt · Erasmus MC, Erasmus University Rotterdam
  5. Theo M. Luider · Erasmus MC, Erasmus University Rotterdam

Methods and tools

Methods it uses

  • PEAKS: Commercial DP-based de novo

Seen in the charts

Back to the full map

Back to top